Robotic vs expert biopsy for obese men with suspected prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two methods of taking prostate biopsies in men with high BMI who have an MRI suspicious for prostate cancer. The goal is to see if robotic-assisted biopsy finds cancer more accurately than an expert doctor doing the biopsy by hand.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older.
- Your PSA blood test must be between 4 and 20 (or a rectal exam feels abnormal).
- You must have a high body mass index (BMI) – at least 28 for Asian men, at least 30 for non-Asian men.
- You must have at least one suspicious spot on an MRI with a PI-RADS score of 3 or more.
- You must be healthy enough for a biopsy through the perineum (the area between the scrotum and anus) with local anesthesia or light sedation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to guide a prostate biopsy using MRI images, to see which better detects clinically significant prostate cancer in men with suspicious MRI findings.
This trial compares two ways to take a prostate biopsy (through the rectum or through the skin between the scrotum and anus) to see which is more accurate. Men with suspicious MRI findings (PI-RADS 3, 4, or 5) who haven't had prostate cancer before may be eligible.
This trial tests a robot-assisted method for taking prostate biopsies using a new type of ultrasound probe. It may help men with certain high-risk features get a more precise diagnosis.
This trial compares two ways to use MRI images during a prostate biopsy to see which finds cancer better. It looks at 'fusion' biopsy (where a computer combines MRI with live ultrasound) versus 'cognitive' biopsy (where the doctor mentally matches the MRI to the ultrasound).
This study compares two ways of doing prostate biopsies (sampling tissue from the prostate) to see if one is better. It is for men who have a suspicious MRI finding on one side of the prostate and have not had a biopsy before. Participation may help determine which method is more accurate and could influence future care.
This study tests whether an artificial intelligence tool for MRI can improve the results of targeted prostate biopsy, compared to the usual method. It could help diagnose prostate cancer more accurately with fewer needles.
Hear when a new Prostate Biopsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.